 Adherance to HAART is of paramount importance. Paterson et al showed that patients should take 95 of their prescribed doses in order to achieve a high likelihood of success and maintaining an undetectable viral load. Poor adherence can lead to serious consequences including failure to prevent viral replication, shortened survival and development of viral resistance. 